×
  • Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Nasal Splints Market

    ID: MRFR/HC/16518-CR
    100 Pages
    Garvit Vyas
    December 2023

    US Nasal Splints Market Research Report By Type (Malleable Nasal Splints, Airway Nasal Splints, Bivalve Nasal Splints) By End-Users (Hospitals & Clinics, Homecare, Research Centers, Others) By Application (Plastic Surgery, Rhinological operations, ENT-Surgery, Others) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Nasal Splints Market Infographic
    Purchase Options

    US Nasal Splints Market Summary

    As per MRFR analysis, the US nasal splints market size was estimated at 455.72 $ Million in 2024. The US nasal splints market is projected to grow from 478.23 $ Million in 2025 to 774.39 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.94% during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The US nasal splints market is experiencing a notable shift towards non-invasive solutions and advanced product designs.

    • The demand for non-invasive nasal splints is rising as patients seek less intrusive treatment options.
    • Technological advancements in product design are enhancing the effectiveness and comfort of nasal splints.
    • The post-operative care segment is witnessing increased focus, driven by the need for improved recovery outcomes.
    • Key market drivers include growing awareness of nasal health and an increase in surgical procedures.

    Market Size & Forecast

    2024 Market Size 455.72 (USD Million)
    2035 Market Size 774.39 (USD Million)

    Major Players

    Medtronic (US), Smith & Nephew (GB), Stryker (US), Boston Scientific (US), Johnson & Johnson (US), B. Braun (DE), ConvaTec (GB), Medi (DE)

    US Nasal Splints Market Trends

    The nasal splints market is currently experiencing notable growth, driven by an increasing awareness of nasal health and the rising prevalence of nasal surgeries. As more individuals seek solutions for nasal obstruction and post-operative care, the demand for effective nasal splints has surged. Innovations in materials and designs are enhancing comfort and efficacy, which appears to be attracting a broader consumer base. Furthermore, the integration of advanced technologies in product development is likely to improve patient outcomes, thereby fostering market expansion. Regulatory support and guidelines from health authorities are also contributing to the market's positive trajectory, ensuring that products meet safety and efficacy standards. In addition, the nasal splints market is witnessing a shift towards minimally invasive procedures, which may further boost the demand for these devices. As healthcare providers increasingly adopt less invasive surgical techniques, the need for supportive devices like nasal splints becomes more pronounced. This trend suggests a potential for sustained growth in the coming years, as both patients and practitioners recognize the benefits of using nasal splints for recovery and comfort. Overall, the market appears poised for continued development, with various factors indicating a favorable environment for innovation and expansion in the nasal splints sector.

    Rising Demand for Non-Invasive Solutions

    There is a growing preference for non-invasive treatment options among patients, which is influencing the nasal splints market. As individuals seek alternatives to more invasive surgical procedures, the demand for nasal splints that facilitate recovery and improve breathing is likely to increase. This trend reflects a broader shift in patient attitudes towards healthcare, emphasizing comfort and convenience.

    Technological Advancements in Product Design

    Innovations in materials and design are transforming the nasal splints market. Manufacturers are increasingly utilizing advanced materials that enhance comfort and effectiveness, which may lead to improved patient compliance. These technological advancements not only improve the functionality of nasal splints but also expand their applications in various medical settings.

    Increased Focus on Post-Operative Care

    The emphasis on post-operative care is becoming more pronounced, which could drive growth in the nasal splints market. As healthcare providers recognize the importance of supporting patients during recovery, the use of nasal splints is likely to gain traction. This trend suggests that the market may see an uptick in demand as practitioners prioritize effective recovery solutions.

    US Nasal Splints Market Drivers

    Growing Geriatric Population

    The expanding geriatric population in the US is a crucial driver for the nasal splints market. As individuals age, they often experience a higher incidence of nasal and respiratory issues, necessitating effective treatment solutions. The elderly population is particularly susceptible to conditions that may require surgical intervention, leading to an increased demand for nasal splints during recovery. Current demographic trends indicate that by 2030, nearly 20% of the US population will be aged 65 and older. This demographic shift suggests a corresponding rise in the need for nasal splints, as healthcare systems adapt to cater to the unique needs of older patients. Consequently, the nasal splints market is poised for growth as it aligns with the healthcare demands of this expanding demographic.

    Increase in Surgical Procedures

    The rise in surgical procedures, particularly those related to nasal and sinus surgeries, significantly impacts the nasal splints market. As surgical techniques advance and become more common, the need for post-operative care solutions, such as nasal splints, becomes increasingly critical. Data suggests that the number of nasal surgeries performed annually in the US has seen a steady increase, with estimates indicating a growth rate of around 5% per year. This trend is likely to continue, as more patients opt for surgical interventions to address chronic nasal issues. Consequently, the nasal splints market is expected to benefit from this surge in surgical activity, as healthcare professionals increasingly utilize nasal splints to aid in recovery and ensure optimal healing outcomes.

    Growing Awareness of Nasal Health

    The increasing awareness regarding nasal health among the population is a pivotal driver for the nasal splints market. As individuals become more informed about the implications of nasal conditions, there is a corresponding rise in demand for effective treatment options. This heightened awareness is reflected in the growing number of educational campaigns and health initiatives aimed at promoting nasal health. Consequently, healthcare providers are more frequently recommending nasal splints as a viable solution for various nasal issues. Market data indicates that the nasal splints market is projected to grow at a CAGR of approximately 6% over the next five years, driven by this awareness. The emphasis on preventive care and early intervention further propels the demand for nasal splints, as patients seek to address nasal problems before they escalate.

    Advancements in Material Technology

    Innovations in material technology are transforming the nasal splints market, offering enhanced comfort and effectiveness. The development of biocompatible materials and customizable designs allows for improved patient experiences and outcomes. These advancements enable manufacturers to produce nasal splints that are not only functional but also comfortable for prolonged use. As healthcare providers increasingly prioritize patient comfort, the demand for these advanced nasal splints is expected to rise. Market analysis indicates that the introduction of new materials could potentially increase market share by up to 15% over the next few years, as patients and healthcare professionals alike seek out superior options that enhance recovery and minimize discomfort.

    Rising Incidence of Allergies and Respiratory Disorders

    The escalating incidence of allergies and respiratory disorders in the US is a significant driver for the nasal splints market. With environmental factors contributing to a rise in conditions such as allergic rhinitis and sinusitis, there is a growing need for effective management solutions. Nasal splints are often recommended to alleviate symptoms and support nasal passages during treatment. Recent statistics indicate that approximately 30% of adults in the US suffer from allergies, which correlates with an increased demand for nasal splints. This trend suggests that as the prevalence of these conditions continues to rise, the nasal splints market will likely expand to meet the needs of affected individuals seeking relief and improved quality of life.

    Market Segment Insights

    By Type: Malleable Nasal Splints (Largest) vs. Airway Nasal Splints (Fastest-Growing)

    In the US nasal splints market, malleable nasal splints hold the largest share, favored for their adaptability and ease of use during recovery. Airway nasal splints, while currently smaller in share, are rapidly gaining popularity due to their innovative design that enhances airflow and comfort for patients. Bivalve nasal splints also play a significant role, although they cater to a specific range of applications within nasal surgeries. The growth trends for nasal splints are driven by increasing surgical procedures and advancements in technology that improve the effectiveness of these devices. Malleable nasal splints continue to dominate due to their reliable performance, while airway nasal splints are on the rise as healthcare providers seek more effective solutions for post-operative care, reflecting a shift towards enhancing patient comfort and recovery times.

    Malleable Nasal Splints (Dominant) vs. Airway Nasal Splints (Emerging)

    Malleable nasal splints are characterized by their flexibility and moldability, making them the preferred choice for many surgeons in the US nasal splints market. Their ability to conform to the patient’s anatomy ensures proper support and helps minimize complications during healing. In contrast, airway nasal splints are emerging as innovative solutions designed to promote better airflow and reduce discomfort. These splints have gained traction among otolaryngologists due to their lightweight materials and streamlined design. This dynamic between the dominant malleable nasal splints and the emerging airway nasal splints illustrates a market responding to both traditional needs and modern patient care expectations.

    By Application: Plastic Surgery (Largest) vs. Rhinological Operations (Fastest-Growing)

    In the US nasal splints market, the dominant segment is Plastic Surgery, accounting for a significant portion of market share compared to other applications. Rhinological operations follow as a notable application, showing promising share potential as it carves out a stronger niche within surgical interventions. The other categories, including ENT-Surgery and Others, contribute to the market but remain less prominent in comparison. Growth trends within the US nasal splints market reveal that the Rhinological operations segment is experiencing rapid expansion, driven by advancements in surgical techniques and increasing patient awareness about nasal procedures. Moreover, the prevalence of nasal disorders and cosmetic procedures continues to fuel demand in this segment, enhancing its attractiveness to providers and patients alike.

    Plastic Surgery (Dominant) vs. Rhinological Operations (Emerging)

    Plastic Surgery represents a well-established and dominant segment in the US nasal splints market, characterized by a robust demand for aesthetic and reconstructive procedures. Its market strength is underpinned by the continued popularity of cosmetic enhancements. In contrast, Rhinological Operations, while currently considered emerging, is swiftly gaining traction owing to rising incidences of nasal deformities and increased focus on treating nasal conditions effectively. The two segments exhibit distinct market characteristics, with Plastic Surgery leading in established treatment preferences, whereas Rhinological Operations is leveraging innovative medical practices to captivate a broader patient base.

    By End-Users: Hospitals & Clinics (Largest) vs. Homecare (Fastest-Growing)

    In the US nasal splints market, the segment distribution reveals that Hospitals & Clinics hold a substantial market share, driven primarily by the demand for post-operative care and treatment in clinical settings. This segment reflects a well-established infrastructure that supports a variety of nasal procedures, contributing to its dominant position. Meanwhile, the Homecare segment is emerging as a significant player, leveraging advancements in convenient medical devices and home-based treatments, appealing to patients seeking comfort and autonomy. Analyzing growth trends, the Homecare segment is witnessing the fastest growth due to increasing patient preference for home treatment solutions, coupled with a rise in digital health technologies. Factors such as the aging population, the frequent need for nasal care, and advancements in splint designs further drive this segment's expansion. Hospitals & Clinics will continue to perform strongly; however, Homecare is rapidly gaining traction as patients become more proactive about their health care options.

    Hospitals & Clinics (Dominant) vs. Homecare (Emerging)

    The Hospitals & Clinics segment remains the dominant force in the US nasal splints market, offering a comprehensive range of services that cater to both surgical and nonsurgical needs. This segment benefits from advanced medical facilities, specialized staff, and collaborations with healthcare professionals, ensuring patient safety and high success rates. Conversely, the Homecare segment, although currently smaller, is rapidly emerging due to changing consumer behaviors and technological innovations. Patients are increasingly preferring home treatments for comfort and convenience, leading to a growth in demand for nasal splints that are easy to use and can be administered without extensive medical supervision. The competition between these segments is crucial as they evolve to meet patients' changing needs.

    Get more detailed insights about US Nasal Splints Market

    Key Players and Competitive Insights

    The nasal splints market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on patient-centric solutions. Key players such as Medtronic (US), Stryker (US), and Johnson & Johnson (US) are at the forefront, leveraging their extensive research and development capabilities to enhance product offerings. Medtronic (US) emphasizes technological advancements in its nasal splint designs, aiming to improve patient outcomes through enhanced comfort and efficacy. Meanwhile, Stryker (US) focuses on expanding its product portfolio through strategic acquisitions, thereby solidifying its market position. Johnson & Johnson (US) adopts a multifaceted approach, integrating digital health solutions into its nasal splint offerings, which reflects a broader trend towards personalized healthcare solutions. Collectively, these strategies contribute to a dynamic competitive environment, where innovation and patient satisfaction are paramount.

    In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. This approach not only enhances operational efficiency but also allows for greater responsiveness to market demands. The competitive structure of the nasal splints market appears moderately fragmented, with several key players exerting influence. However, the collective actions of these companies suggest a trend towards consolidation, as they seek to leverage synergies and enhance their competitive edge.

    In October 2025, Medtronic (US) announced the launch of a new line of biodegradable nasal splints, which are designed to reduce environmental impact while maintaining high performance. This strategic move aligns with growing consumer demand for sustainable medical products and positions Medtronic (US) as a leader in eco-friendly innovations within the market. The introduction of biodegradable materials could potentially reshape consumer preferences and set new industry standards.

    In September 2025, Stryker (US) completed the acquisition of a smaller firm specializing in advanced nasal splint technologies. This acquisition is likely to enhance Stryker's product offerings and expand its market reach, allowing the company to tap into new customer segments. The integration of innovative technologies from the acquired firm may also bolster Stryker's competitive position by providing differentiated products that meet evolving patient needs.

    In August 2025, Johnson & Johnson (US) entered into a strategic partnership with a digital health startup to develop a telehealth platform specifically for nasal surgery patients. This collaboration aims to streamline patient care and improve post-operative monitoring, reflecting a broader trend towards digitalization in healthcare. By integrating technology into its product ecosystem, Johnson & Johnson (US) is likely to enhance patient engagement and satisfaction, which are critical factors in the competitive landscape.

    As of November 2025, the nasal splints market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. Companies that can effectively navigate these trends are likely to secure a competitive advantage in the market.

    Key Companies in the US Nasal Splints Market market include

    Future Outlook

    US Nasal Splints Market Future Outlook

    The nasal splints market is projected to grow at a 4.94% CAGR from 2024 to 2035, driven by increasing surgical procedures and advancements in product technology.

    New opportunities lie in:

    • Development of biodegradable nasal splints for enhanced patient comfort.
    • Expansion of e-commerce platforms for direct-to-consumer sales.
    • Partnerships with healthcare providers for integrated patient care solutions.

    By 2035, the nasal splints market is expected to achieve substantial growth and innovation.

    Market Segmentation

    US Nasal Splints Market Type Outlook

    • Malleable Nasal Splints
    • Airway Nasal Splints
    • Bivalve Nasal Splints

    US Nasal Splints Market End-Users Outlook

    • Hospitals & Clinics
    • Homecare
    • Research Centers
    • Others

    US Nasal Splints Market Application Outlook

    • Plastic Surgery
    • Rhinological operations
    • ENT-Surgery
    • Others

    Report Scope

    MARKET SIZE 2024455.72(USD Million)
    MARKET SIZE 2025478.23(USD Million)
    MARKET SIZE 2035774.39(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR)4.94% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Million
    Key Companies ProfiledMedtronic (US), Smith & Nephew (GB), Stryker (US), Boston Scientific (US), Johnson & Johnson (US), B. Braun (DE), ConvaTec (GB), Medi (DE)
    Segments CoveredType, Application, End-Users
    Key Market OpportunitiesAdvancements in biocompatible materials enhance patient comfort and expand applications in the nasal splints market.
    Key Market DynamicsRising demand for innovative nasal splints driven by evolving consumer preferences and regulatory advancements in healthcare.
    Countries CoveredUS

    Leave a Comment

    FAQs

    What is the projected market size of the US Nasal Splints Market in 2024?

    The US Nasal Splints Market is projected to be valued at 463.05 million USD in 2024.

    What will the market value of the US Nasal Splints Market be in 2035?

    By 2035, the US Nasal Splints Market is expected to reach a valuation of 1001.99 million USD.

    What is the expected compound annual growth rate (CAGR) for the US Nasal Splints Market from 2025 to 2035?

    The market is expected to experience a CAGR of 7.269% from 2025 to 2035.

    Which segment of nasal splints holds the largest market share based on the 2024 figures?

    In 2024, Bivalve Nasal Splints hold the largest market share, valued at 176.98 million USD.

    What is the estimated market value for Malleable Nasal Splints in 2035?

    Malleable Nasal Splints are estimated to be valued at 306.05 million USD in 2035.

    Which key players are significant in the US Nasal Splints Market?

    Notable competitors include Smith and Nephew, Medtronic, and Acclarent among others.

    What is the expected market size for Airway Nasal Splints in 2024?

    The market value for Airway Nasal Splints is projected to be 147.45 million USD in 2024.

    What are the growth drivers for the US Nasal Splints Market?

    Growing demand for nasal surgeries and technological advancements are key growth drivers.

    How does the market size of Bivalve Nasal Splints change from 2024 to 2035?

    Bivalve Nasal Splints are expected to grow from 176.98 million USD in 2024 to 376.44 million USD in 2035.

    What opportunities exist in the US Nasal Splints Market for new entrants?

    Emerging trends in minimally invasive procedures present significant opportunities for new entrants into the market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions